Medivation Names Rick Bierly Chief Financial Officer

Medivation Names Rick Bierly Chief Financial Officer 
SAN FRANCISCO, CA -- (Marketwired) -- 03/31/14 --  Medivation, Inc.
(NASDAQ: MDVN) today announced the appointment of Rick Bierly as
chief financial officer, effective March 31, 2014. Rick will serve as
Medivation's principal financial and accounting officer and will
report to David Hung, M.D., president and chief executive officer.  
As previously announced, after more than 10 years as Medivation's
chief business and financial officer, Patrick Machado is retiring
from his position.  
"Pat's contributions to our success have been invaluable as we've
grown from a small start up into a commercial organization with a
product approved in over 35 countries around the world. We are
extremely fortunate to have his help as Medivation transitions to a
new CFO," said David Hung, M.D., president and chief executive
officer of Medivation. "Rick brings many years of deep and varied
financial expertise in the Life Sciences industry and will be an
asset to Medivation as we continue to grow our business to capture
new opportunities. On behalf of the board and the other members of
the executive team, it is a pleasure to welcome Rick to Medivation." 
Rick Bierly added, "This is an exciting time to be joining Medivation
as the company looks to expand its XTANDI(R) (enzalutamide) franchise
and invest in new programs in areas of unmet medical need. I look
forward to working closely with the Medivation team to achieve the
organization's growth goals."  
Rick Bierly brings to Medivation over 30 years' experience in finance
roles at Glaxo-SmithKline, Aventis, Centocor and Johnson & Johnson.
Among these roles were biotechnology CFO, diagnostics CFO, Treasurer,
External Reporting director, head of shared services and operational
finance roles in support of sales, marketing, supply chain and R&D.
He began his career in public accounting at Ernst & Young (EY), and
most recently served as an executive director in EY's Financial
Accounting Advisory Services practice. Rick holds a Bachelor of
Business Administration degree from Pennsylvania State University and
is a CPA in PA and NJ. 
About Medivation  
Medivation, Inc. is a biopharmaceutical company focused on the rapid
development of novel therapies to treat serious diseases for which
there are limited treatment options. Medivation aims to transform the
treatment of these diseases and offer hope to critically ill patients
and their families. For more information, please visit us at
www.medivation.com.  
Contacts:
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900 
 
 
Press spacebar to pause and continue. Press esc to stop.